|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009013,
umls-concept:C0021469,
umls-concept:C0026926,
umls-concept:C0039195,
umls-concept:C0086418,
umls-concept:C0205369,
umls-concept:C0441655,
umls-concept:C0487637,
umls-concept:C0567416,
umls-concept:C1332714,
umls-concept:C1332802,
umls-concept:C1416857
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-9-12
|
|
pubmed:abstractText |
Antigen-specific cytolytic CD4+ T lymphocytes control Mycobacterium tuberculosis infection by secreting cytokines and by killing macrophages that have phagocytosed the pathogen. However, lysis of the latter cells promotes microbial dissemination, and other macrophages engulf the released bacteria. Subsequently, CD4+ T-cell-mediated killing of macrophages goes on, and this persistent process may hamper control of infection, unless regulatory mechanisms maintain a subtle balance between lysis of macrophages by cytolytic CD4+ cells and activation of cytolytic CD4+ cells by infected macrophages. We asked whether inhibitory molecules expressed by CD4+ cytolytic T lymphocytes could play a role in such a balance. To this end, human CD4+ T-cell clones specific for M. tuberculosis were produced that displayed an autologous major histocompatibility complex class II-restricted lytic ability against purified protein derivative (PPD)-pulsed antigen-presenting cells. All T-cell clones expressed CD152 (cytotoxic T-lymphocyte antigen 4 [CTLA-4]) and CD85/leukocyte immunoglobulin-like receptor 1 (LIR-1)/immunoglobulin-like transcript 2 (ILT2) inhibitory receptors, but not CD94 and the killer inhibitory receptor (or killer immunoglobulin-like receptor [KIR]) p58.2. CD3-mediated activation of the clones was inhibited in a redirected killing assay in which CD152 and CD85/LIR-1/ILT2 were cross-linked. Specific antigen-mediated proliferation of the clones was also sharply reduced when CD152 and CD85/LIR-1/ILT2 were cross-linked by specific monoclonal antibody (MAb) followed by goat anti-mouse antiserum. In contrast, blockade of the receptors by specific MAb only increased their proliferation. Production of interleukin 2 (IL-2) and gamma interferon (IFN-gamma) by the T-cell clones was also strongly reduced when CD152 and CD85/LIR-1/ILT2 were cross-linked. The lytic activity of the T-cell clones against PPD-pulsed autologous monocytes or Epstein-Barr virus-activated B cells was increased by blockade and decreased by cross-linking of the receptors. These results indicate that CD152 and CD85/LIR-1/ILT2 play a role in the regulation of the antigen-specific activity of CD4+ cytolytic T lymphocytes against PPD-presenting cells.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10229815,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10358758,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10412980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10417139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10591185,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-10817964,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-11034379,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-11083801,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-11120840,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-11175847,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-11274928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-2870027,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-7493761,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-7507960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-7836763,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-7964446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-8100846,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-8103743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-8303277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-8787672,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-8943377,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9010724,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9182685,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9285411,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9382880,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9498779,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9521319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9535647,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9605147,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9755341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9842885,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11553539-9916682
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ctla4 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoconjugates,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/LILRB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Tuberculin,
http://linkedlifedata.com/resource/pubmed/chemical/abatacept
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6022-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11553539-Antigens, CD,
pubmed-meshheading:11553539-Antigens, CD3,
pubmed-meshheading:11553539-Antigens, Differentiation,
pubmed-meshheading:11553539-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11553539-CTLA-4 Antigen,
pubmed-meshheading:11553539-Cell Division,
pubmed-meshheading:11553539-Clone Cells,
pubmed-meshheading:11553539-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:11553539-Down-Regulation,
pubmed-meshheading:11553539-Humans,
pubmed-meshheading:11553539-Immunoconjugates,
pubmed-meshheading:11553539-Interferon-gamma,
pubmed-meshheading:11553539-Interleukin-2,
pubmed-meshheading:11553539-Lymphocyte Activation,
pubmed-meshheading:11553539-Mycobacterium tuberculosis,
pubmed-meshheading:11553539-Receptors, Immunologic,
pubmed-meshheading:11553539-Tuberculin
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
|
|
pubmed:affiliation |
Department of Experimental Medicine, Human Anatomy Section, University of Genoa, 16132 Genoa, Italy.
|
|
pubmed:publicationType |
Journal Article
|
